Bayer Cardiovascular Exchange Summit

Publish date:
General News

Bayer plc are pleased to announce the date for the second Cardiovascular Exchange Summit Meeting, a non-promotional meeting organised in partnership with the British Cardiovascular Society (BCS) and the Primary Care Cardiovascular Society (PCCS)

This face-to-face meeting will take place on 14 and 15 September 2023 at the Royal College of General Practitioners, 30 Euston Square, London NW1 4FB. The meeting will focus on the scientific exchange of disease-related clinical data as well as expert opinion and experience from specialists in the field of cardiovascular and cardiorenal conditions.

This year’s meeting will focus on supporting the NHS to achieve its CVD ambitions by leading through innovation. There will be an opportunity to address the challenges of the primary-secondary care interface in the management of cardiovascular disease (CVD) and to explore how pathways for CVD management and prevention can be improved, as well as looking at future opportunities arising from digitalisation of care provision.

Join us together with other peers and leading experts for interactive sessions, workshops and networking. A detailed invitation, including the agenda for the meeting will be sent to you soon. Invitations are to CVD clinical experts including cardiovascular specialists, national CVD clinical and research leads, and primary care network (PCN) clinical leads in the UK. Places are limited and will be booked on a first come first served basis with places reserved primarily to those experts listed previously.

Contributions captured during the meeting and knowledge generated may be published in the form of a post-meeting report. To register your interest please email:

Yours sincerely

Dr Raj Thakkar Primary Care GP, Buckinghamshire, CKD Representative & President of The PCCS

Professor Vijay Kunadian Academic Consultant, Interventional Cardiologist, Newcastle upon Tyne

Dr Guy Lloyd Consultant Cardiologist, Barts Heart Centre

This meeting is organised and fully funded by Bayer, in partnership with the British Cardiovascular Society (BCS) and the Primary Care Cardiovascular Society (PCCS).

MA-UN-CAR-GB-0029 July 2023